Blue Horseshoe Stocks: BABA Review & More

Alibaba Group Holding Ltd. BABA – Update

After noticing a strong double-bottom setup on the chart, we threw our hat in the ring with BABA yesterday morning by formulating an options idea to track during what we described as an overdue recovery.

The stock did exhibit the first signs of that recovery, thereby producing some nice single-session gain opportunities for ourselves and our readers. Our targeted options were the BABA 05/04 $180-187.50 Calls, and regardless of the strike price chosen within our designated range, notable able intraday profits were there for the taking.

$180 Calls – Range: 3.60-5.10  – Max Gain: 42%
$182.50 Calls – Range: 2.80-3.75 – Max Gain: 34%
$185 Calls – Range: 2.21-3.05 – Max Gain: 38%
$187.50 Calls – Range: 1.74-2.27 – Max Gain: 30%

There is, of course, plenty of time before these contracts expire, so we’ll continue monitor these ideas going forward in the event that BABA stock continues its rebounding ways. Further opportunities may arise and we’ll want to be ready.


Tandem Diabetes Care, Inc. TNDM – Update

We also wanted to update everyone on another longer term idea we formulated that has definitely worked out in our favor. We’ve had a number of stocks that we signaled our interest in earlier in 2018 slowly and steadily make monster moves for us, and TNDM is the latest one.

We initially slated this play for observation In mid-January, and after only a slight consolidation at the beginning of February, the stock established support at a low of 2.14, reversed, and began a really impressive bull run that was amplified by a significant degree yesterday. TNDM ran to a new high of 7.22. That works out to a 237% increase here in the early goings of the 2018 calendar year.


Extended Watchlist:
PVG, CRIS, EYEG, CBAY, PRPO

Comments are closed.